Please Wait.....
Report
North America Retinal Imaging Devices Market Forecast 2026-2034
Market Report I 2026-02-10 I 205 Pages I Inkwood Research
KEY FINDINGS
The North America retinal imaging devices market size is valued at $1,643.22 million as of 2026 and is expected to reach $2,909.75 million by 2034, progressing with a CAGR of 7.40% during the forecast years, 2026-2034.
MARKET INSIGHTS
North America dominates the global retinal imaging devices market due to advanced healthcare infrastructure, substantial research and development investments, and high adoption rates of cutting-edge ophthalmic diagnostic equipment. The region benefits from well-established reimbursement frameworks that facilitate access to optical coherence tomography systems and fundus cameras across diverse care settings.
Moreover, the escalating prevalence of diabetes and aging demographics creates a persistent demand for retinal screening technologies. According to the CDC's Vision and Eye Health Surveillance System, approximately 9.6 million Americans lived with diabetic retinopathy in 2021, representing 26.4% of those with diabetes. Furthermore, projections indicate this figure will reach 14.7 million by 2050.
Additionally, government initiatives promoting preventive eye care and teleophthalmology programs expand screening accessibility in underserved rural communities. Leading manufacturers like Carl Zeiss Meditec, Topcon Corporation, and Heidelberg Engineering maintain significant operational presence throughout North America, driving continuous innovation in retinal diagnostic imaging technology.
REGIONAL ANALYSIS
The North America retinal imaging devices market growth assessment includes the analysis of the United States and Canada.
The United States represents the largest market for retinal imaging equipment within North America, propelled by high healthcare expenditure, extensive ophthalmology infrastructure, and favorable regulatory environments. The U.S. healthcare system encompasses thousands of hospitals, specialty eye clinics, and diagnostic centers equipped with advanced retinal imaging cameras and OCT angiography systems.
Medicare and private insurance coverage facilitate widespread adoption of these diagnostic technologies for diabetic retinopathy screening and age-related macular degeneration monitoring. According to research published in JAMA Ophthalmology, diabetic retinopathy prevalence among those with diabetes ranged from 20.8% in Nevada to 31.3% in Massachusetts, highlighting significant geographic variation. This disparity creates opportunities for targeted deployment of portable retinal imaging devices in underserved regions.
Moreover, the United States leads in artificial intelligence integration for automated retinal image analysis. The FDA has approved multiple autonomous AI systems, including IDx-DR and EyeArt, enabling primary care physicians to conduct diabetic retinopathy screenings without specialist oversight. According to recent implementations, approximately 198 AI-equipped cameras have been deployed across five U.S. health systems since 2020, covering roughly 151,000 diabetic patients.
Additionally, teleophthalmology programs connecting rural screening sites with urban ophthalmologists expand access to retinal diagnostic services. Veterans Affairs facilities, Indian Health Service clinics, and federally qualified health centers increasingly adopt connected retinal imaging devices to address ophthalmologist workforce shortages. Consequently, the U.S. market presents substantial growth opportunities for vendors offering portable, AI-enabled retinal imaging systems with telehealth capabilities.
Canada exhibits steady growth in the retinal imaging devices market, driven by universal healthcare coverage, increasing diabetes prevalence, and government support for preventive eye care programs. Over four million Canadians have been diagnosed with diabetes, with this figure projected to exceed five million by 2033.
Provincial health systems increasingly invest in tele-ophthalmology infrastructure to serve remote and northern communities, particularly Indigenous populations experiencing disproportionately high diabetes rates. Aligning with this, Manitoba's teleophthalmology screening program exemplifies successful implementation, with trained nurses conducting retinal examinations using portable fundus cameras in rural settings.
These initiatives create demand for durable, user-friendly retinal imaging equipment suitable for non-specialist operators. Furthermore, Canadian healthcare providers prioritize cost-effective solutions that balance diagnostic accuracy with total ownership expenses, presenting opportunities for vendors offering competitively priced optical coherence tomography devices with comprehensive service agreements.
SEGMENTATION ANALYSIS
The North America retinal imaging devices market is segmented into device, application, and indication. The device segment is further categorized into optical coherence tomography (OCT) devices (spectral-domain OCT, swept-source OCT, handheld OCT), fluorescein angiography devices, fundus cameras (mydriatic fundus cameras, non-mydriatic fundus cameras, hybrid fundus cameras, ROP fundus cameras), retinal ultrasound imaging systems (ophthalmic A-scan ultrasound, ophthalmic B-scan ultrasound, ophthalmic ultrasound biomicroscopes, ophthalmic pachymeters), ultra widefield retinal imaging devices, widefield retinal imaging devices, and other devices.
Optical coherence tomography (OCT) devices command the dominant position in North America's retinal imaging equipment market due to their superior diagnostic capabilities and widespread clinical adoption. These sophisticated systems utilize low-coherence interferometry to generate high-resolution cross-sectional images of retinal structures with unprecedented detail, enabling early detection of diabetic macular edema, glaucomatous optic nerve changes, and age-related macular degeneration.
Spectral-domain OCT technology currently represents the clinical standard, offering rapid scanning speeds up to 100,000 A-scans per second while maintaining excellent image quality. Tertiary care hospitals, academic medical centers, and retina specialty practices extensively utilize OCT systems for both initial diagnosis and ongoing treatment monitoring. Consequently, declining equipment costs and expanding Medicare reimbursement codes for OCT examinations facilitate adoption in community ophthalmology practices and optometry clinics.
Vendors offering integrated OCT-angiography capabilities without contrast dye injection gain competitive advantages, as these systems provide comprehensive vascular assessment alongside structural imaging. Furthermore, the segment benefits from continuous technological innovation, with manufacturers introducing artificial intelligence-powered analysis software that automates measurement and progression detection, thereby reducing interpretation time while improving diagnostic consistency across diverse clinical settings.
COMPETITIVE INSIGHTS
Some of the top players operating in the North America retinal imaging devices market include Carl Zeiss Meditec AG, Topcon Corporation, Heidelberg Engineering GmbH, Canon Inc, etc.
Carl Zeiss Meditec AG stands as a leading manufacturer of ophthalmic diagnostic and surgical equipment, headquartered in Jena, Germany, with substantial North American operations. The company specializes in advanced retinal imaging technologies, particularly its flagship CIRRUS OCT platform, which dominates the spectral-domain optical coherence tomography segment. Zeiss's product portfolio encompasses comprehensive solutions, including fundus cameras, OCT-angiography systems, surgical microscopes, and integrated diagnostic workstations for comprehensive eye examinations.
Additionally, the company provides AngioPlex OCT-A technology that visualizes retinal vasculature without invasive dye injection. Zeiss serves diverse customer segments, including hospital ophthalmology departments, retina specialty practices, comprehensive ophthalmology clinics, and optometry offices throughout North America. The company's business model emphasizes premium product positioning, extensive customer support networks, comprehensive training programs, and ongoing software upgrades that maintain installed base loyalty while driving recurring revenue streams from service contracts and disposable components.
COMPANY PROFILES
1. CANON INC
2. CARL ZEISS MEDITEC AG
3. ESCALON MEDICAL CORP
4. FORUS HEALTH PVT LTD
5. HEIDELBERG ENGINEERING GMBH
6. KOWA COMPANY LTD
7. NIDEK CO LTD
8. OPTOS PLC
9. SANTEC CORPORATION
10. TOPCON CORPORATION
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & FORECAST
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. WIDESPREAD ADOPTION OF FUNDUS CAMERAS AND OCT SYSTEMS IS DRIVEN BY RISING SCREENING NEEDS FOR DIABETIC RETINOPATHY AND AGE-RELATED MACULAR DEGENERATION
2.5.2. HOSPITALS AND DIAGNOSTIC CLINICS ACCOUNT FOR THE LARGEST SHARE DUE TO HIGH PATIENT FOOTFALL AND INTEGRATED OPHTHALMOLOGY SETUPS
2.5.3. PORTABLE AND HANDHELD RETINAL IMAGING DEVICES ARE GAINING TRACTION IN RURAL AND PRIMARY CARE SETTINGS
2.5.4. DEVELOPED MARKETS DOMINATE REVENUE WHILE EMERGING ECONOMIES SHOW FASTER VOLUME GROWTH
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. INCREASING GLOBAL PREVALENCE OF DIABETES AND AGING POPULATION IS EXPANDING THE AT-RISK PATIENT BASE
3.1.2. GOVERNMENT AND NGO LED EYE SCREENING PROGRAMS ARE BOOSTING DEMAND FOR RETINAL DIAGNOSTIC TOOLS
3.1.3. TECHNOLOGICAL ADVANCES IN OCT AI ASSISTED DIAGNOSTICS AND IMAGE QUALITY ARE IMPROVING CLINICAL OUTCOMES
3.1.4. RISING AWARENESS AMONG PHYSICIANS AND PATIENTS ABOUT EARLY DETECTION OF RETINAL DISORDERS IS SUPPORTING MARKET EXPANSION
3.2. KEY RESTRAINTS
3.2.1. HIGH CAPITAL COST OF ADVANCED RETINAL IMAGING SYSTEMS LIMITS ADOPTION IN SMALL CLINICS
3.2.2. LACK OF TRAINED OPHTHALMOLOGISTS AND TECHNICIANS CONSTRAINS EFFECTIVE UTILIZATION IN LOW-INCOME REGIONS
3.2.3. REIMBURSEMENT VARIABILITY ACROSS COUNTRIES AFFECTS PURCHASE DECISIONS BY HEALTHCARE PROVIDERS
3.2.4. REGULATORY APPROVAL AND DEVICE CERTIFICATION REQUIREMENTS CAN DELAY PRODUCT COMMERCIALIZATION
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. INTEGRATION OF ARTIFICIAL INTELLIGENCE FOR AUTOMATED RETINAL IMAGE ANALYSIS IS ACCELERATING
4.1.2. SHIFT TOWARD NON-MYDRIATIC AND PATIENT-FRIENDLY IMAGING SYSTEMS IS IMPROVING SCREENING COMPLIANCE
4.1.3. GROWING USE OF TELE OPHTHALMOLOGY IS DRIVING DEMAND FOR CONNECTED RETINAL IMAGING DEVICES
4.1.4. MANUFACTURERS ARE FOCUSING ON COMPACT AND PORTABLE DESIGNS TO EXPAND POINT OF CARE APPLICATIONS
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR NORTH AMERICA
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
4.6. VALUE CHAIN ANALYSIS
4.6.1. RAW MATERIAL SUPPLIERS
4.6.2. OPTICAL COMPONENTS
4.6.3. DEVICE MANUFACTURING
4.6.4. SOFTWARE DEVELOPMENT
4.6.5. DISTRIBUTION CHANNELS
4.6.6. HOSPITALS AND CLINICS
4.6.7. AFTERSALES SUPPORT
4.7. KEY BUYING CRITERIA
4.7.1. IMAGE RESOLUTION
4.7.2. CLINICAL ACCURACY
4.7.3. EASE OF USE
4.7.4. TOTAL COST OWNERSHIP
4.8. REGULATORY FRAMEWORK
5. RETINAL IMAGING DEVICES MARKET BY DEVICE
5.1. OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES
5.1.1. SPECTRAL-DOMAIN OCT (SD-OCT)
5.1.2. SWEPT-SOURCE OCT (SS-OCT)
5.1.3. HANDHELD OCT
5.2. FLUORESCEIN ANGIOGRAPHY DEVICES
5.3. FUNDUS CAMERAS
5.3.1. MYDRIATIC FUNDUS CAMERAS
5.3.2. NON-MYDRIATIC FUNDUS CAMERAS
5.3.3. HYBRID FUNDUS CAMERAS
5.3.4. ROP FUNDUS CAMERAS
5.4. RETINAL ULTRASOUND IMAGING SYSTEMS
5.4.1. OPHTHALMIC A-SCAN ULTRASOUND
5.4.2. OPHTHALMIC B-SCAN ULTRASOUND
5.4.3. OPHTHALMIC ULTRASOUND BIOMICROSCOPES
5.4.4. OPHTHALMIC PACHYMETERS
5.5. ULTRA WIDEFIELD RETINAL IMAGING DEVICES
5.6. WIDEFIELD RETINAL IMAGING DEVICES
5.7. OTHER DEVICES
6. RETINAL IMAGING DEVICES MARKET BY APPLICATION
6.1. DISEASE DIAGNOSIS
6.2. TREATMENT MONITORING
6.3. RESEARCH AND DEVELOPMENT
7. RETINAL IMAGING DEVICES MARKET BY INDICATION
7.1. DIABETIC RETINOPATHY
7.2. AGE-RELATED MACULAR DEGENERATION (AMD)
7.3. GLAUCOMA
7.4. RETINAL VEIN OCCLUSION
7.5. OTHER INDICATIONS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. NORTH AMERICA MARKET DRIVERS
8.1.3. NORTH AMERICA MARKET CHALLENGES
8.1.4. KEY PLAYERS IN NORTH AMERICA RETINAL IMAGING DEVICES MARKET
8.1.5. COUNTRY ANALYSIS
8.1.5.1. UNITED STATES
8.1.5.1.1. UNITED STATES MARKET SIZE & OPPORTUNITIES
8.1.5.2. CANADA
8.1.5.2.1. CANADA MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. CANON INC
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. PRODUCT LIST
9.2.1.3. STRENGTHS & CHALLENGES
9.2.2. CARL ZEISS MEDITEC AG
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCT LIST
9.2.2.3. STRENGTHS & CHALLENGES
9.2.3. ESCALON MEDICAL CORP
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. PRODUCT LIST
9.2.3.3. STRENGTHS & CHALLENGES
9.2.4. FORUS HEALTH PVT LTD
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCT LIST
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. HEIDELBERG ENGINEERING GMBH
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. PRODUCT LIST
9.2.5.3. STRENGTHS & CHALLENGES
9.2.6. KOWA COMPANY LTD
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCT LIST
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. NIDEK CO LTD
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. PRODUCT LIST
9.2.7.3. STRENGTHS & CHALLENGES
9.2.8. OPTOS PLC
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCT LIST
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. SANTEC CORPORATION
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCT LIST
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. TOPCON CORPORATION
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. PRODUCT LIST
9.2.10.3. STRENGTHS & CHALLENGES
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - RETINAL IMAGING DEVICES
TABLE 2: MARKET BY DEVICE, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 3: MARKET BY DEVICE, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 4: MARKET BY OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 5: MARKET BY OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 6: MARKET BY FUNDUS CAMERAS, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 7: MARKET BY FUNDUS CAMERAS, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 8 MARKET BY RETINAL ULTRASOUND IMAGING SYSTEMS, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 9: MARKET BY RETINAL ULTRASOUND IMAGING SYSTEMS, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 10: MARKET BY APPLICATION, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 11: MARKET BY APPLICATION, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 12: MARKET BY INDICATION, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 13: MARKET BY INDICATION, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 14: NORTH AMERICA MARKET, COUNTRY ANALYSIS, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 15: NORTH AMERICA MARKET, COUNTRY ANALYSIS, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 16: KEY PLAYERS OPERATING IN THE NORTH AMERICAN MARKET
TABLE 17: LIST OF MERGERS & ACQUISITIONS
TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 20: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR NORTH AMERICA
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: SEGMENT GROWTH POTENTIAL, BY DEVICE, IN 2025
FIGURE 9: OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 10: SEGMENT GROWTH POTENTIAL, BY OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES, IN 2025
FIGURE 11: SPECTRAL-DOMAIN OCT (SD-OCT) MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 12: SWEPT-SOURCE OCT (SS-OCT) MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 13: HANDHELD OCT MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 14: FLUORESCEIN ANGIOGRAPHY DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 15: FUNDUS CAMERAS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 16: SEGMENT GROWTH POTENTIAL, BY FUNDUS CAMERAS, IN 2025
FIGURE 17: MYDRIATIC FUNDUS CAMERAS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 18: NON-MYDRIATIC FUNDUS CAMERAS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 19: HYBRID FUNDUS CAMERAS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 20: ROP FUNDUS CAMERAS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 21: RETINAL ULTRASOUND IMAGING SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 22: SEGMENT GROWTH POTENTIAL, BY RETINAL ULTRASOUND IMAGING SYSTEMS, IN 2025
FIGURE 23: OPHTHALMIC A-SCAN ULTRASOUND MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 24: OPHTHALMIC B-SCAN ULTRASOUND MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 25: OPHTHALMIC ULTRASOUND BIOMICROSCOPES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 26: OPHTHALMIC PACHYMETERS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 27: ULTRA WIDEFIELD RETINAL IMAGING DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 28: WIDEFIELD RETINAL IMAGING DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 29: OTHER DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 30: SEGMENT GROWTH POTENTIAL, BY APPLICATION, IN 2025
FIGURE 31: DISEASE DIAGNOSIS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 32: TREATMENT MONITORING MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 33: RESEARCH AND DEVELOPMENT MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 34: SEGMENT GROWTH POTENTIAL, BY INDICATION, IN 2025
FIGURE 38: DIABETIC RETINOPATHY MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 35: AGE-RELATED MACULAR DEGENERATION (AMD) MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 36: GLAUCOMA MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 37: RETINAL VEIN OCCLUSION MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 38: OTHER INDICATIONS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 39: NORTH AMERICA RETINAL IMAGING DEVICES MARKET, COUNTRY OUTLOOK, 2025 & 2034 (IN %)
FIGURE 40: UNITED STATES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 41: CANADA MARKET SIZE, 2026-2034 (IN $ MILLION)
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - RETINAL IMAGING DEVICES
TABLE 2: MARKET BY DEVICE, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 3: MARKET BY DEVICE, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 4: MARKET BY OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 5: MARKET BY OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 6: MARKET BY FUNDUS CAMERAS, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 7: MARKET BY FUNDUS CAMERAS, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 8 MARKET BY RETINAL ULTRASOUND IMAGING SYSTEMS, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 9: MARKET BY RETINAL ULTRASOUND IMAGING SYSTEMS, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 10: MARKET BY APPLICATION, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 11: MARKET BY APPLICATION, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 12: MARKET BY INDICATION, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 13: MARKET BY INDICATION, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 14: NORTH AMERICA MARKET, COUNTRY ANALYSIS, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 15: NORTH AMERICA MARKET, COUNTRY ANALYSIS, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 16: KEY PLAYERS OPERATING IN THE NORTH AMERICAN MARKET
TABLE 17: LIST OF MERGERS & ACQUISITIONS
TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 20: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR NORTH AMERICA
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: SEGMENT GROWTH POTENTIAL, BY DEVICE, IN 2025
FIGURE 9: OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 10: SEGMENT GROWTH POTENTIAL, BY OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES, IN 2025
FIGURE 11: SPECTRAL-DOMAIN OCT (SD-OCT) MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 12: SWEPT-SOURCE OCT (SS-OCT) MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 13: HANDHELD OCT MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 14: FLUORESCEIN ANGIOGRAPHY DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 15: FUNDUS CAMERAS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 16: SEGMENT GROWTH POTENTIAL, BY FUNDUS CAMERAS, IN 2025
FIGURE 17: MYDRIATIC FUNDUS CAMERAS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 18: NON-MYDRIATIC FUNDUS CAMERAS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 19: HYBRID FUNDUS CAMERAS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 20: ROP FUNDUS CAMERAS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 21: RETINAL ULTRASOUND IMAGING SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 22: SEGMENT GROWTH POTENTIAL, BY RETINAL ULTRASOUND IMAGING SYSTEMS, IN 2025
FIGURE 23: OPHTHALMIC A-SCAN ULTRASOUND MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 24: OPHTHALMIC B-SCAN ULTRASOUND MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 25: OPHTHALMIC ULTRASOUND BIOMICROSCOPES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 26: OPHTHALMIC PACHYMETERS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 27: ULTRA WIDEFIELD RETINAL IMAGING DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 28: WIDEFIELD RETINAL IMAGING DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 29: OTHER DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 30: SEGMENT GROWTH POTENTIAL, BY APPLICATION, IN 2025
FIGURE 31: DISEASE DIAGNOSIS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 32: TREATMENT MONITORING MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 33: RESEARCH AND DEVELOPMENT MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 34: SEGMENT GROWTH POTENTIAL, BY INDICATION, IN 2025
FIGURE 38: DIABETIC RETINOPATHY MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 35: AGE-RELATED MACULAR DEGENERATION (AMD) MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 36: GLAUCOMA MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 37: RETINAL VEIN OCCLUSION MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 38: OTHER INDICATIONS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 39: NORTH AMERICA RETINAL IMAGING DEVICES MARKET, COUNTRY OUTLOOK, 2025 & 2034 (IN %)
FIGURE 40: UNITED STATES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 41: CANADA MARKET SIZE, 2026-2034 (IN $ MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security